- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01383057
Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery
February 15, 2012 updated by: Innovative Medical
The purpose of this study is to prove the efficacy and safety of the Femtosecond laser to create a clear corneal incision during cataract surgery.
Study Overview
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Goodlettsville, Tennessee, United States
- Loden Vision Centers
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Study participants must have a cataract for which phacoemulsification extraction and posterior IOL implantation has been planned in at least one eye.
Study participants should be capable of achieving better than 20/30 Snellen best corrected distance vision after cataract extraction and IOL implantation.
- The surgeon may use the Mentor Potential Acuity Meter (PAM) laser interferometer, McIntyre Pinhole, or his/her judgment to estimate the patient's potential acuity.
Exclusion Criteria:
- Concurrent participation or participation in the last thirty days in any other clinical trial.
- Known steroid IOP responder
- Taking medications that may affect vision, IOP or ease of cataract surgery (e.g., Flomax, Glaucoma mediations, etc.)
- Acute or chronic disease or illness that would increase risk or confound study results (e.g., uncontrolled diabetes mellitus, immunocompromised, etc.)
- Uncontrolled systemic or ocular disease
- Corneal abnormalities (e.g., stromal, epithelial or endothelial dystrophies)
- Pseudoexfoliation
- Ocular hypertension IOP >25 mmHg by tonometry or glaucomatous changes in the optic nerve
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Femtosecond Laser
|
Using the Femtosecond Laser to make a clear corneal incision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraocular Pressure
Time Frame: 3 months
|
Measure the fluid pressure inside the eye
|
3 months
|
Uncorrected and Best corrected Visual Acuity
Time Frame: one month
|
Vision obtained with the best possible lens correction (Best corrected).
Vision obtained without the use of glasses or contact lenses (Uncorrected).
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
February 1, 2012
Study Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
June 24, 2011
First Submitted That Met QC Criteria
June 27, 2011
First Posted (Estimate)
June 28, 2011
Study Record Updates
Last Update Posted (Estimate)
February 17, 2012
Last Update Submitted That Met QC Criteria
February 15, 2012
Last Verified
February 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FEMTO 2011-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataracts
-
Johnson & Johnson Surgical Vision, Inc.Recruiting
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataractsUnited States
-
Wenzhou Medical UniversityCompleted
-
Medical University of ViennaCompleted
-
Hermann Eye CenterCompleted
-
Mark Packer, MD, FACSCompletedCataractsUnited States
-
Medical University of ViennaCompleted
Clinical Trials on Femtosecond Laser
-
The Cleveland ClinicAlcon ResearchCompleted
-
Innovative MedicalCompleted
-
Medical University of ViennaRecruiting
-
Durrie VisionAlcon ResearchCompletedMyopiaUnited States
-
Technolas Perfect Vision GmbHCompleted
-
Johnson & Johnson Surgical Vision, Inc.RecruitingRefractive ErrorSingapore, India
-
Abbott Medical OpticsCompleted
-
Ospedale Santo StefanoIstituto di Fisica ApplicataCompletedCorneal Opacity | Keratoconus | Corneal DystrophiesItaly
-
Istanbul UniversityCompletedAnterior Chamber Inflammation | Cornea | Refractive SurgeryTurkey